Volume 47, Issue 3 pp. 529-535
ORIGINAL ARTICLE

Cold Stored Platelets: A Solution for Platelet Aggregation External Quality Assessment/Proficiency Testing

Christopher Reilly-Stitt

Corresponding Author

Christopher Reilly-Stitt

UK NEQAS (Blood Coagulation), Sheffield, UK

Correspondence:

Christopher Reilly-Stitt ([email protected])

Search for more papers by this author
Ian Jennings

Ian Jennings

UK NEQAS (Blood Coagulation), Sheffield, UK

Search for more papers by this author
Steve Kitchen

Steve Kitchen

UK NEQAS (Blood Coagulation), Sheffield, UK

Search for more papers by this author
Michael Cahillane

Michael Cahillane

Welsh Blood Service, Talbot Green, Llantrisant, UK

Search for more papers by this author
Christine Saunders

Christine Saunders

Welsh Blood Service, Talbot Green, Llantrisant, UK

Search for more papers by this author
Chloe George

Chloe George

Welsh Blood Service, Talbot Green, Llantrisant, UK

Search for more papers by this author
Tom Scorer

Tom Scorer

University Hospital Plymouth, Plymouth, UK

Centre of Defence Pathology, Royal Centre of Defence Medicine, Birmingham, UK

Search for more papers by this author
Isobel D. Walker

Isobel D. Walker

UK NEQAS (Blood Coagulation), Sheffield, UK

Search for more papers by this author
First published: 10 March 2025

Funding: The authors received no specific funding for this work.

ABSTRACT

Background

To achieve accreditation for ISO 15189, laboratories are required to either participate in EQA exercises or intra-laboratory comparisons to meet the standard. Light transmission aggregometry performed by laboratory scientists for the clinical investigation of possible platelet function defects is time dependent. Current EQA available audits the interpretation of platelet aggregation traces.

Objectives

Could NEQAS BC provide external quality assessment (EQA) material to centres employing Light Transmission Aggregometry LTA for clinical investigation of platelet function? The use of fresh donor platelets could audit more of the analytical and post analytical aspects of light transmission aggregation than currently available.

Methods

A pool of donor platelets was split into aliquots that were distributed to testing centres across England, Scotland and Wales for testing within a 72 h window. Participating centres employed their locally validated testing methods for LTA assays, for agonists including ADP; Arachidonic acid; Collagen; Epinephrine; Ristocetin; TRAP and U46619.

Results

Five different aggregation platforms were used including: Chronolog 700; Helena Aggram; PAP-8; Stago TA-8V and Sysmex CN-series. Sample packs were tested through the 72 h window with most sites performing LTA on the EQA material on day one of the three.

Conclusion

The % consensus of interpretations provided by participants for agonists including: ADP; Arachidonic acid; Collagen; Epinephrine and Ristocetin ranged from 94% to 100% indicating that the material is stable plus centres using different aggregometers returned the same clinical interpretations.

Conflicts of Interest

The authors declare no conflicts of interest.

Data Availability Statement

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.